Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.2951
Delayed Data
As of Feb 09
 +0.0051 / +1.76%
Today’s Change
0.20
Today|||52-Week Range
2.74
-36.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues28.9M38.3M36.3M36.6M
 
 
 
 
 
Cost of Goods Sold24.1M30.3M29.9M29.1M
 
 
 
 
 
Depreciation And Amortization1.1M1.2M1.3M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income3.7M6.8M5.1M6.2M
 
 
 
 
 
General Expenses10.4M9.7M10.9M10.2M
 
 
 
 
 
Research And Development--232.0K414.0K1.0M
 
 
 
 
Total Operating Expenses35.6M41.2M42.1M40.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.7M-2.9M-5.8M-4.0M
 
 
 
 
 
Extraordinary Charge-2.1M-28.0K-116.0K-28.0K
 
 
 
 
 
Interest Expense On Debt602.0K848.0K884.0K969.0K
 
 
 
 
 
Other Expenses-19.0K-58.0K-97.0K1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.4M-3.8M-6.9M-5.0M
 
 
 
 
 
Income Taxes-4.9M-73.0K-177.0K-180.0K
 
 
 
 
 
Discontinued Operations-3.0M-125.0K-264.0K-76.0K
 
 
 
 
 
Net Income-7.5M-3.9M-7.0M-4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.9M15.0M15.2M15.7M
 
 
 
 
 
Shares To Calculate EPS Diluted14.9M15.0M15.2M15.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.50-$0.26-$0.46-$0.31
 
 
 
 
 
EPS Diluted-$0.50-$0.26-$0.46-$0.31